PBOV1 Is a Human De Novo Gene with Tumor-Specific Expression That Is Associated with a Positive Clinical Outcome of Cancer

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Samusik, Nikolay ^a   Krukovskaya, Larisa ^b   Meln, Irina ^c   Shilov, Evgeny ^b   Kozlov, Andrey P ^b,d  

^a MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^b Biomedical Center   (Russian Federation)

^c ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

^d ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER TESTIS ANTIGEN; SONIC HEDGEHOG PROTEIN;

ADRENAL TUMOR; ARTICLE; BRAIN TUMOR; BREAST CANCER; CANCER RISK; COLON TUMOR; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; FETUS; GALLBLADDER TUMOR; GENE; GENE EXPRESSION; GENE SEQUENCE; GLIOMA; HUMAN; HUMAN TISSUE; LIVER TUMOR; LUNG TUMOR; NEOPLASM; OVARY TUMOR; PANCREAS TUMOR; PAROTID GLAND TUMOR; PBOV1 GENE; PROMOTER REGION; PROSTATE TUMOR; RECURRENT CANCER; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL INTESTINE TUMOR; SPLEEN TUMOR; STOMACH TUMOR; TESTIS TUMOR; THYMOMA; URETER TUMOR; UTERINE TUBE TUMOR; UTERUS TUMOR;

ADULT; AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; EVOLUTION, MOLECULAR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HEDGEHOG PROTEINS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYLOGENY; PROGNOSIS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 84873917649     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056162     Document Type: Article

References (57)

1. Kaessmann H, (2010) Origins, evolution and phenotypic impact of new genes. Genome Research 20: 1313-1326.
2. Long M, Betrán E, Thornton K, Wang W, (2003) The origin of new genes: glimpses from the young and old. Nature reviews Genetics 4: 865-875.
3. Snel B, Bork P, Huynen MA, (2002) Genomes in flux: the evolution of archaeal and proteobacterial gene content. Genome research 12: 17-25.
4. Toll-Riera M, Bosch N, Bellora N, Castelo R, Armengol L, et al. (2009) Origin of primate orphan genes: a comparative genomics approach. Molecular biology and evolution 26: 603-612.
5. Cai J, Zhao R, Jiang H, Wang W, (2008) De novo origination of a new protein-coding gene in Saccharomyces cerevisiae. Genetics 179: 487-496.
6. Li D, Dong Y, Jiang Y, Jiang H, Cai J, et al. (2010) A de novo originated gene depresses budding yeast mating pathway and is repressed by the protein encoded by its antisense strand. Cell research 20: 408-420.
7. Knowles DG, McLysaght A, (2009) Recent de novo origin of human protein-coding genes. Genome research 19: 1752-1759.
8. Li C-Y, Zhang Y, Wang Z, Zhang Y, Cao C, et al. (2010) A human-specific de novo protein-coding gene associated with human brain functions. PLoS computational biology 6: e1000734 Available: http://www.ploscompbiol.org/article/info%3Adoi%2F10.1371%2Fjournal.pcbi.1000734 Accessed 7 Jan 2012.
9. Wu D-D, Irwin DM, Zhang Y-P, (2011) De novo origin of human protein-coding genes. PLoS genetics 7: e1002379 Available: http://dx.plos.org/10.1371/journal.pgen.1002379. Accessed 15 Jul 2012.
10. Kozlov AP, (2010) The possible evolutionary role of tumors in the origin of new cell types. Medical hypotheses 74: 177-185.
11. Kozlov AP, (1996) Gene competition and the possible evolutionary role of tumours. Medical hypotheses 46: 81-84.
12. Stauffer Y, Theiler G, Sperisen P, Lebedev Y, Jongeneel CV, (2004) Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. Cancer immunity: a journal of the Academy of Cancer Immunology 4: 2.
13. Kapranov P, Willingham AT, Gingeras TR, (2007) Genome-wide transcription and the implications for genomic organization. Nature reviews Genetics 8: 413-423.
14. Ortmann CA, Eisele L, Nückel H, Klein-Hitpass L, Führer A, et al. (2008) Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia. Annals of hematology 87: 809-818.
15. Wischnewski F, Pantel K, Schwarzenbach H, (2006) Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1,-A2,-A3, and-A12 in human cancer cells. Molecular cancer research: MCR 4: 339-349.
16. Fisher MA, McKinley KL, Bradley LH, Viola SR, Hecht MH, (2011) De novo designed proteins from a library of artificial sequences function in Escherichia coli and enable cell growth. PloS one 6: e15364 Available: http://dx.plos.org/10.1371/journal.pone.0015364. Accessed 26 Jul 2012.
17. Kozlov AP, Galachyants YP, Dukhovlinov IV, Samusik NA, Baranova AV, et al. (2006) Evolutionarily new sequences expressed in tumors. Infectious agents and cancer 1: 8 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1779766&tool=pmcentrez&rendertype=abstract. Accessed 28 December 2011.
18. Samusik NA, Galachyants YP, Kozlov AP, (2011) Analysis of evolutionary novelty of tumor-specifically expressed sequences. Russian Journal of Genetics: Applied Research 1: 138-148.
19. Clamp M, Fry B, Kamal M, Xie X, Cuff J, et al. (2007) Distinguishing protein-coding and noncoding genes in the human genome. Proceedings of the National Academy of Sciences of the United States of America 104: 19428-19433.
20. Krukovskaia LL, Samusik ND, Shilov ES, Polev DE, Kozlov AP, (2010) [Tumor-specific expression of PBOV1, a new gene in evolution]. Voprosy onkologii 56: 327-332.
21. An G, Ng AY, Meka CSR, Luo G, Bright SP, et al. (2000) Cloning and Characterization of UROC28, a Novel Gene Overexpressed in Prostate, Breast, and Bladder Cancers. Cancer Res 60: 7014-7020.
22. Kamagata C, Tsuji N, Kondoh K, Sasaki M, Kobayashi D, et al. (2002) Enhanced expression of the UROC28 gene in human breast cancer: relationship to ERBB2 gene expression. Anticancer research 22: 4087-4091.
23. Blanchette M, Kent WJ, Riemer C, Elnitski L, Smit AFA, et al. (2004) Aligning multiple genomic sequences with the threaded blockset aligner. Genome research 14: 708-715.
24. Vasudevan S, Peltz SW, Wilusz CJ, (2002) Non-stop decay-a new mRNA surveillance pathway. Bio Essays: news and reviews in molecular, cellular and developmental biology 24: 785-788.
25. Dunn CW, Hejnol A, Matus DQ, Pang K, Browne WE, et al. (2008) Broad phylogenomic sampling improves resolution of the animal tree of life. Nature 452: 745-749.
26. De Magalhães JP, Church GM, (2007) Analyses of human-chimpanzee orthologous gene pairs to explore evolutionary hypotheses of aging. Mechanisms of ageing and development 128: 355-364.
27. Comeron JM, (1999) K-Estimator: calculation of the number of nucleotide substitutions per site and the confidence intervals. Bioinformatics 15: 763-764.
28. Guigó R (1999) DNA Composition, Codon Usage and Exon Prediction. In: Bishop MJ, editor. Genetic Databases. Academic Press.
29. Plotkin JB, Robins H, Levine AJ, (2004) Tissue-specific codon usage and the expression of human genes. Proceedings of the National Academy of Sciences of the United States of America 101: 12588-12591.
30. Aydin Z, Altunbasak Y, Borodovsky M (2006) Protein secondary structure prediction for a single-sequence using hidden semi-Markov models. BMC bioinformatics 7: 178. Available:http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1479840&tool=pmcentrez&rendertype=abstract. Accessed 27 Feb 2012.
31. Zhang Y, (2008) I-TASSER server for protein 3D structure prediction. BMC bioinformatics 9: 40 Available:http://www.biomedcentral.com/1471-2105/9/40. Accessed 16 June 2011.
32. Ferrè F, Clote P, (2006) DiANNA 1.1: an extension of the DiANNA web server for ternary cysteine classification. Nucleic acids research 34: W182-5.
33. Loizidou MA, Cariolou MA, Neuhausen SL, Newbold RF, Bashiardes E, et al. (2010) Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population. Breast cancer research and treatment 121: 147-156.
34. Ringnér M, Fredlund E, Häkkinen J, Borg Å, Staaf J, (2011) GOBO: gene expression-based outcome for breast cancer online. PloS one 6: e17911 Available:http://dx.plos.org/10.1371/journal.pone.0017911. Accessed 22 Mar 2012.
35. Ma X-J, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, et al. (2004) A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer cell 5: 607-616.
36. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer cell 9: 157-173.
37. Nanni S, Priolo C, Grasselli A, D'Eletto M, Merola R, et al. (2006) Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer. Molecular cancer research 4: 79-92.
38. Valen E, Sandelin A, (2011) Genomic and chromatin signals underlying transcription start-site selection. Trends in genetics 27: 475-485.
39. Saxonov S, Berg P, Brutlag D, (2006) A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proceedings of the National Academy of Sciences 103: 1412-1417.
40. Birney E, Stamatoyannopoulos Ja, Dutta A, Guigó R, Gingeras TR, et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
41. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer cell 10: 515-527.
42. Augello MA, Hickey TE, Knudsen KE, (2011) FOXA1: master of steroid receptor function in cancer. The EMBO journal 30: 3885-3894.
43. Mansour AA, Nissim-Eliraz E, Zisman S, Golan-Lev T, Schatz O, et al. (2011) Foxa2 regulates the expression of Nato3 in the floor plate by a novel evolutionarily conserved promoter. Molecular and cellular neurosciences 46: 187-199.
44. Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, et al. (2008) A paracrine requirement for hedgehog signalling in cancer. Nature 455: 406-410.
45. Schreiber H, Ward PL, Rowley DA, Stauss HJ, (1988) Unique tumor-specific antigens. Annual review of immunology 6: 465-483.
46. Coggin JH, Barsoum AL, Rohrer JW, Thurnher M, Zeis M, (2005) Contemporary definitions of tumor specific antigens, immunogens and markers as related to the adaptive responses of the cancer-bearing host. Anticancer research 25: 2345-2355.
47. Low JA, De Sauvage FJ, (2010) Clinical experience with Hedgehog pathway inhibitors. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 28: 5321-5326.
48. Nuber N, Curioni-Fontecedro A, Matter C, Soldini D, Tiercy JM, et al. (2010) Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients. Proceedings of the National Academy of Sciences of the United States of America 107: 15187-15192.
49. Schlom J, (2012) Therapeutic Cancer Vaccines: Current Status and Moving Forward. Journal of the National Cancer Institute 104: 599-613.
50. DuPage M, Mazumdar C, Schmidt LM, Cheung AF, Jacks T, (2012) Expression of tumour-specific antigens underlies cancer immunoediting. Nature 482: 405-409.
51. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, et al. (2001) An Overview of the MAGE Gene Family with the Identification of All Human Members of the Family. Cancer Res 61: 5544-5551.
52. Katsura Y, Satta Y, (2011) Evolutionary history of the cancer immunity antigen MAGE gene family. PloS one 6: e20365 Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0020365. Accessed 7 Jan 2013.
53. Falkmer S, Emdin SO, Ostberg Y, Mattisson A, Sjöbeck ML, et al. (1976) Tumor pathology of the hagfish, Myxine glutinosa, and the river lamprey, Lampetra fluviatilis. A light-microscopical study with particular reference to the occurrence of primary liver carcinoma, islet-cell tumors, and epidermoid cysts of the skin. Progress in experimental tumor research 20: 217-250.
54. Sambrook J (2001) Molecular Cloning: A Laboratory Manual, Third Edition (3 volume set).Cold Spring Harbor: Cold Spring Harbor Laboratory Press. p. 130.
55. Murphy WJ, Eizirik E, O'Brien SJ, Madsen O, Scally M, et al. (2001) Resolution of the early placental mammal radiation using Bayesian phylogenetics. Science 294: 2348-2351.
56. Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A, (2010) Detection of nonneutral substitution rates on mammalian phylogenies. Genome research 20: 110-121.
57. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921.